Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

thinkemotive

Biomarin

NICE knocks back BioMarin’s Batten disease drug

£500,000 list price too high without long-term data, says watchdog

- PMLiVE

Amgen, Servier start second phase 3 trial of heart failure hope

Treatment is one of few in underserved area

- PMLiVE

The importance of co-creation with patients

Overcoming the barriers

- PMLiVE

McCann Health’s next challenge: creative differentiation

New global chief creative officer Matt Eastwood talks to PME about McCann Health’s future as a creative advertising agency

- PMLiVE

Merck & Co to buy IO specialists Immune Design for $300m

US giant looks to next generation technology

- PMLiVE

Greater Manchester backs move to outcome-based payment

Region teams up with Cancer Research UK to accelerate change

- PMLiVE

More good news, and some bad, for Merck’s Keytruda

A rare setback in phase 3 liver cancer trial

- PMLiVE

Xencor’s Novartis-partnered bispecific on hold after patient deaths

The two death’s included one case of CRS

- PMLiVE

Three billboards on the road to multichannel

Chris Ross examines the trends driving multichannel communication in 2019

How Medisafe is using AI to improve patient adherence

Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence.

Blue Latitude Health

- PMLiVE

KYNE expands presence to London

Joanne Wunder to lead its European offering

- PMLiVE

Cell therapy disruptor Mogrify gains $3.7m in funding and a new leader

Former Horizon chief Darrin Disley to lead the company through series A round

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links